 | Virpax Pharmaceuticals, Inc. | |||
| NCM : VRPX || Location: United States | ||||
$3.37+0.2 (+6.49%) |
0.0 M | 3.08 - 3.37 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.030 M |
| March 15, 2024 | 0.024 M |
| Feb. 29, 2024 | 0.011 M |
| Feb. 15, 2024 | 0.062 M |
| Jan. 31, 2024 | 0.071 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -2.75 | -3.90 | -41.61% |
| 09/30/2023 | -2.65 | -5.10 | -92.31% |
| 09/30/2022 | -0.46 | -0.65 | -41.61% |
| 06/30/2022 | -0.45 | -0.50 | -11.41% |
VRPX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1.171M | Shares Float | 1.142M |
| Short Float | 0.030M | Market Cap | 3.70M |
| Institution ownership | 3.26% | Insider ownership | 25.722% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -12.97 | Forward EPS | -7.40 |